Maze Therapeutics ($MAZE) Insider Trading & Smart Money Activity
Maze Therapeutics, Inc. ($MAZE) has 5 insider trades on file. In the last 12 months on the open market, no insider bought and 4 insiders sold ($2.30M), net -$2.30M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 4
- Net insider $ (12 mo)
- -$2.30M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
MAZE insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · $725.50K | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 1 · $202.92K | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 2 · $1.37M | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All MAZE insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Coloma Jason VChief Executive Officer | Sell (Open-market sale) 10b5-1 | 34.50K sh | $932.26K | -2.9% | — | |||||
| Insider | Bernstein HaroldPresident, R&D & CMO | Sell (Open-market sale) 10b5-1 | 16.14K sh | $434.74K | -2.9% | — | |||||
| Insider | Dandekar AtulCSBO | Sell (Open-market sale) 10b5-1 | 7.50K sh | $202.92K | -2.2% | — | |||||
| Insider | Jason ColomaChief Executive Officer | Sell (Open-market sale) 10b5-1 | 23.86K sh | $621.68K | +13.0% | +4.8% | — | ||||
| Insider | Jason ColomaChief Executive Officer | Sell (Open-market sale) 10b5-1 | 3.99K sh | $103.82K | +13.4% | +11.4% | Read |
1W / 1M / 6M = how MAZE moved from the trade or filing date.
Insider trading in MAZE: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Coloma Jason V | Chief Executive Officer | 1 | -$932.26K | Oct 1, 2026 | |
| Bernstein Harold | President, R&D & CMO | 1 | -$434.74K | Oct 1, 2026 | |
| Dandekar Atul | CSBO | 1 | -$202.92K | Sep 29, 2026 | |
| Jason Coloma | Chief Executive Officer | 2 | -$725.50K | Jun 23, 2026 |
Frequently asked questions
Are MAZE insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 4 insiders made 5 open-market sales worth $2.30M, a net -$2.30M.
What is the latest insider trade in MAZE?
Coloma Jason V, Chief Executive Officer filed a sell (open-market sale) of 34.50K sh worth $932.26K on Oct 1, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.